Solitary fibrous tumor (SFT) is a rare tumor with incidence <2% in all soft tissue tumors. About 30% of SFTs arise in thoracic cavity, 30% arise from the intra-abdominal cavity, and another 20% occur in head and neck. We presented a case with a painless, slow-growing intra-abdominal tumor for more than a decade. Physical examinations, blood test, and image studies provide little clues preoperatively. Definite diagnosis relies on pathological confirmation. Currently, there are numerous immunohistochemistry tools to facilitate making diagnosis correctly.
INTRODUCTION
Solitary fibrous tumors (SFTs) are uncommon mesenchymal neoplasms first described in 1931 1 and account <2% of all soft tissue tumors. 2 Initially, SFTs are thought to be intrathoracic tumors. Moreover, recent reports unveil that SFTs occur almost everywhere of human body including the intra-abdominal cavity, central nervous system, head and neck, bone, salivary gland, thyroid, liver, and prostate.
3 SFTs of the abdominal wall are extremely uncommon and there are only 16 cases had been reported till date. 4 SFTs are most commonly diagnosed from fifth to seventh decades, and the mean age is 58 years. There is no sex predilection.
2 In this report, we describe a new case of SFT that originates from rectus sheath and discuss the clinical symptoms, signs, image findings, and pathological characteristics.
CASE REPORT
A 42-year-old female presented to our surgery department because of a slow-growing abdominal mass for the past 10 years. Her family and medical history were unremarkable, and she had no history of previous abdominal surgery. There
The postoperative course was uneventful, and she was discharged 5 days after the surgery.
DISCUSSION
Clinical symptoms and signs of SFTs vary based on the location and size of the tumor. A palpable, nontender, slow-growing mass is the most common presentation. Large tumor may cause gastrointestinal symptoms such as nausea, vomiting, and constipation.
Imaging modalities such as CT and MR could help to diagnose SFT. On CT, SFT shows a well-circumscribed and hypervascular mass with external compression of adjacent organs. Calcification is rare in SFT. Central hypodense indicates tumor necrosis or cystic change. 5 In our case, the CT images are compatible with these image features. On MR, SFT usually presents with intermediate intensity on T1-weighted image and heterogenous hypointense on T2-weighted image, which is related to hypercellularity or collagen. Intense enhancement is seen after the administration of gadolinium contrast material. 5, 6 However, this case demonstrates a high signal intensity on T1-weighted image before administration of gadolinium and is less common.
Recognizing typical morphology and specific immunohistochemical findings are keys to diagnose SFT on histological examination. Grossly, the tumor usually presents a sharply circumscribed mass with smooth, bosselated, or lobulated external surface. 7 Microscopically, classical morphological appearance including "patternless pattern" caused by variable spindled cells arrayed in the stroma. Furthermore, prominent and anastomosing "staghorn" capillaries are also observed. 8, 9 Enzinger and Smith published criteria to identify malignant SFT including ≥4 mitotic figures/10 hpf, larger size, high cellularity, nuclear pleomorphism, and presence of hemorrhage or necrosis.
10
Since the histologic characteristics are relatively nonspecific to diagnose SFT, immunohistochemistry plays a vital role to help diagnose and differentiate from other spindle cell tumors. Conventional markers of SFT including diffuse strong positive of CD34, 11 moderately positive of BcL-2 and CD99, and absence of S100, actin, and DOG1. Furthermore, newer immunohistochemistry STAT6 test to detect NAB2-STAT6 fusion gene had been used to differentiate SFT from other mimics and reached significant high sensitivity and specificity. 12, 13 In our case, both histologic characteristics and immunohistochemistry tests showed classic SFT appearance.
Differential diagnosis of tumor arising from rectus sheath including desmoid tumor, hematoma, and infection.
14 The most common tumor arising from rectus sheath is desmoid tumor. Other etiologies including hematoma and infection processes such as scar abscess or diverticulitis. Clinical presentations and image characteristics of desmoid tumor on CT and MR mimic SFTs.
5 Therefore, surgical pathology is the cornerstone of making diagnosis. Unlike SFTs, desmoid tumor shows reactive actin and nonreactive CD34 on immunohistochemistry tests. 15 Hematoma of rectus sheath cannot be accurately diagnosed solely based on symptoms and signs (such as anorexia, nausea, fever, and tachycardia) due to lack of specificity. Hence, ultrasound or CT plays a role of making diagnosis and furthermore preventing unnecessary surgery. Most hematomas could be managed conservatively. The third common mass of rectus sheath is infection. When a mass accompanied with fever, tenderness and leukocytosis raise the suspicion of infection. Numerous infectious processes such as scar abscess, diverticulitis, and Crohn's disease had been reported to cause rectus sheath mass. Some will be resolved with antibiotics alone and others may need surgical or percutaneous drainage. 14 Surgical resection with curative intent is the mainstay therapy for SFT. 16 Adjuvant radiation therapy and chemotherapy are not recommended contemporarily because of the lack of validating data to support these treatments. Newer molecularly target agent therapy is still under-investigated.
CONCLUSION
We present a rare SFT of rectus sheath in a middle-aged woman. Preoperative diagnosis of the disease is difficult because of the nonspecific findings on physical examinations and imaging studies. Correct diagnosis of the tumor needs surgical en bloc resection and histopathological confirmation.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest. 
